Canton Strategic Holdings (CNTN) Change in Cash (2021 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Change in Cash came in at $24.5 million in Q1 2026, up 1086.51% YoY from $2.1 million in Q1 2025, and up 160.01% on a QoQ basis from $9.4 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Change in Cash (2021 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 6 years of Change in Cash data on file, last reported at $24.5 million in Q1 2026.
- Quarterly Change in Cash rose 1086.51% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.5 million (up 650.32% YoY) and the FY2025 annual result came in at $13.5 million, up 282.67% from the prior year.
- Change in Cash advanced to $24.5 million in Q1 2026, from $9.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $24.5 million in Q1 2026 to a low of -$3.1 million in Q3 2024.
- A 5-year average of $2.4 million and a median of -$1.1 million in 2022 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 6665.0% in 2022, down 24311.56% in 2022.
- Tracing CNTN's Change in Cash over 5 years: stood at -$1.1 million in 2022, then soared by 859.23% to $8.2 million in 2023, then sank by 114.73% to -$1.2 million in 2024, then surged by 875.59% to $9.4 million in 2025, then soared by 160.01% to $24.5 million in 2026.
- The last three Change in Cash figures came in at $24.5 million (Q1 2026), $9.4 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | -3.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.71 Mn |
| Mar 31, 2026 | 24.50 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -531,463.00 |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | 334,825.00 |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | -1.89 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | -40,739.00 |
| Sep 30, 2021 | 15,824.00 |